PERPHENAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS
Risk for at least one adverse event per patient · patients with schizophrenia
Comparison 1: PERPHENAZINE showed no clear difference in adverse effects ‐ at least one adverse effect compared with LOW‐POTENCY ANTIPSYCHOTIC DRUGS (low certainty).
1 finding from 1 review
- Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes onlyRR 0.83 [0.36, 1.95]2 studies · 165 participantsLow